TD Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

TD Asset Management’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,121	Closed	-$102K	–	1441
2023 Q3	$102K	Buy	24,121 +11,317	+88%	+$77.9K	﹤0.01%	1384
2023 Q2	$79.8K	Buy	12,804 +975	+8%	+$9.52K	﹤0.01%	1389
2023 Q1	$140K	Hold	11,829	–	–	﹤0.01%	1395
2022 Q4	$167K	Sell	11,829 -1,660	-12%	-$40.5K	﹤0.01%	1399
2022 Q3	$285K	Buy	13,489 +4,719	+54%	+$93K	﹤0.01%	1374
2022 Q2	$172K	Buy	+8,770	New	+$704K	﹤0.01%	1392
2021 Q4	–	Sell	-8,770	Closed	-$872K	–	1541
2021 Q3	$872K	Hold	8,770	–	–	﹤0.01%	1282
2021 Q2	$863K	Buy	+8,770	New	+$875K	﹤0.01%	1290

Other funds holding SNTI

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

8GI

8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

TD Asset Management's SNTI Position: Q4 2023 in Review

TD Asset Management sold out of Senti Biosciences Holdings (SNTI) in Q4 2023, closing a stake of 24,121 shares — an estimated $102K sold.

TD Asset Management first reported a position in SNTI in Q2 2021 and held it in 8 quarters. The position peaked at $872K in Q3 2021. 25 funds tracked by Wall St. Rank hold SNTI as of Q4 2023.

TD Asset Management reported no remaining Senti Biosciences Holdings position as of Q4 2023 after selling out during the quarter.
TD Asset Management sold 24,121 Senti Biosciences Holdings shares in Q4 2023, an estimated $102K.
TD Asset Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 8 quarters.
TD Asset Management's Senti Biosciences Holdings position peaked at $872K in Q3 2021.
25 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.